Watch Ticker

Lexeo Therapeutics, Inc. Common Stock

Go to Lexeo Therapeutics, Inc. Common Stock Website

$4.73

0.00 (0.00%)

Live

Previous Close

$4.73

Day Range

$0 - $0

Previous Day Range

$4.6117 - $4.81

Market Cap

$257.5 million USD

Day Vol.

Previous Day Vol.

174559

Currency

USD

Primary Exchange

None

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene thera...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Lexeo Therapeutics - Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

Lexeo Therapeutics announces positive interim data for its gene therapy candidate LX2006 in treating Friedreich ataxia cardiomyopathy, with participants showing clinically significant improvements in cardiac biomarkers and increased frataxin expression. The company plans to initiate a registrational study by early 2026.

Related tickers: LXEO.

Read Full Article

Marketbeat.Com - 2 Stocks Riding the Biotech Surge With Major Catalysts Ahead

The biotechnology sector has experienced significant volatility, with Tonix Pharmaceuticals and Lexeo Therapeutics seeing major stock price surges. These surges were driven by positive regulatory updates and financial results, respectively, indicating potential long-term value for these companies.

Related tickers: TNXP, LXEO.

Read Full Article

Trending Tickers

Please sign in to view